NCT06228248

Brief Summary

Multidrug resistant bacteria (MDR) pose a threat to the safety of patients worldwide. Drug resistant bacteria are commonly present in hospital environments and can cause infections, often leading to outbreaks within hospitals. Cross transmission through medical staff has been proven to be a significant cause of MDR bacterial transmission in hospitals. Although some studies have shown that the detection of gut drug-resistant bacteria in healthcare workers is similar to that in healthy individuals, these studies are limited to small sample sizes and detection methods. Here, the investigator characterize the differences between ARG colonization among healthcare workers and healthy populations through deep metagenomics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

8 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2024

Completed
16 days until next milestone

Study Start

First participant enrolled

January 18, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 29, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2024

Completed
Last Updated

February 26, 2025

Status Verified

February 1, 2024

Enrollment Period

9 months

First QC Date

January 2, 2024

Last Update Submit

February 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Differences in GUT ARG abundance between two groups

    After conducting metagenomic testing, the investigator will analyze the raw data according to the preset protocol process and report the gut ARG abundance of different individuals. Subsequently, the difference in ARG abundance between the two groups of patients will be compared.

    1 year

Secondary Outcomes (1)

  • The association of occupational exposure time in the ICU environment and ARG

    1 year

Study Arms (2)

medical worker

Medical workers working in clinical settings, including nurses, doctors, and Health care worker.

Other: metagenomics

health population

Healthy individuals who do not engage in medical work

Other: metagenomics

Interventions

Feces used for metagenomic testing

health populationmedical worker

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study included medical workers and health control. The investigator excluded underlying diseases that may have an impact on the gut microbiome, and also excluded individuals who had used broad-spectrum antibiotics within 6 months.

You may qualify if:

  • Age greater than 18 years old
  • The subjects fully understand and sign the informed consent form

You may not qualify if:

  • Existence of gastrointestinal diseases, malignant tumors, and psychiatric disorders
  • Have taken broad-spectrum antibiotics within 6 months
  • Pregnant women
  • For healthy control:
  • Age greater than 18 years old
  • The subjects fully understand and sign the informed consent form
  • Previously or currently engaged in medical related work
  • Existence of gastrointestinal diseases, malignant tumors, and psychiatric disorders
  • Have taken broad-spectrum antibiotics within 6 months
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

First Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310000, China

Location

The First Hospital of Jiaxing

Jiaxing, China

Location

Lishui People's Hospital

Lishui, China

Location

The First People's Hospital of Pinghu

Pinghu, China

Location

Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University

Taizhou, China

Location

Henan Provincial People's Hospital

Zhengzhou, China

Location

The Fifth Clinical Medical College of Henan University of Chinese Medicine

Zhengzhou, China

Location

The Second Affiliated Hospital of Zhengzhou University

Zhengzhou, China

Location

Related Publications (1)

  • Huang L, Li K, Peng C, Gu S, Huang X, Gao C, Ren X, Cheng M, He G, Xu Y, Jiang Y, Wang H, Wang M, Shen P, Wang Q, He X, Zhong L, Wang S, Wang N, Zhang G, Cai H, Jiang C. Elevated antibiotic resistance gene abundance of ICU healthcare workers, a multicentre, cross-sectional study. Crit Care. 2025 Apr 30;29(1):170. doi: 10.1186/s13054-025-05408-5.

Biospecimen

Retention: SAMPLES WITH DNA

Fecal specimens are used for extracting DNA and conducting metagenomic sequencing

Study Officials

  • Lingtong Huang, M.D.

    First Affiliated Hospital of Zhejiang University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 2, 2024

First Posted

January 29, 2024

Study Start

January 18, 2024

Primary Completion

October 10, 2024

Study Completion

November 10, 2024

Last Updated

February 26, 2025

Record last verified: 2024-02

Locations